Effects of bis(2-butoxyethyl) phthalate exposure in utero on the development of fetal Leydig cells in rats

After gestational exposure, BBOP inhibits phosphorylation of AKT1, AKT2, ERK1/2, thus possibly down-regulating fetal Leydig cell (FLC) gene expression and leading to the reduction its proteins, thereby resulting in decrease in INSL3 and testosterone (T) production. [Display omitted] •Bis(2-butoxyethyl) phthalate disrupts fetal Leydig cell development.•Bis(2-butoxyethyl) phthalate lowers testosterone production in fetal testis.•Bis(2-butoxyethyl) phthalate increases Leydig cell number.•Bis(2-butoxyethyl) phthalate inhibits the phosphorylation of AKT1, AKT2, and ERK1/2 signaling in fetal testis. Phthalates are plasticizers widely found in the environment. They are potential endocrine disruptors. Bis(2-butoxyethyl) phthalate (BBOP) is a unique phthalate that contains oxygen atoms in the carbon backbone. Little is known about its reproductive and developmental toxicity. The objective of this study was to determine the effect of BBOP on fetal Leydig cell development after in utero exposure to rats. Sprague Dawley pregnant dams were randomly allocated into 6 groups, and were gavaged with BBOP (0, 10, 100, 250, 500, and 1000 mg/kg body weight/day) from gestational day (GD) 14–21. Seven of the 8 dams in the 1000 mg/kg BBOP group died before giving birth. Twelve of the 20 dams in the 500 mg/kg BBOP group had whole litter loss. BBOP significantly reduced the body weight of dams and male offspring and serum testosterone level and anogenital distance of male fetus on GD 21 at 500 mg/kg. BBOP markedly increased fetal Leydig cell proliferation and number at 500 mg/kg while inducing their abnormal aggregation at 250 and 500 mg/kg. BBOP down-regulated the expression of Lhcgr, Scarb1, Star, Cyp11a1, Hsd3b1, Cyp17a1, Hsd17b3, Insl3, and Nr5a1 at various doses while up-regulating the expression of Sertoli cell gene Fshr and Sox9. The phosphorylation of AKT1, AKT2, and ERK1/2 was also markedly reduced by BBOP. In conclusion, BBOP in utero exposure can disrupt fetal Leydig cell development, possibly via the mechanism that may include inhibiting the phosphorylation of AKT1, AKT2, and ERK1/2.